Tower Research Capital LLC (Trc) Femasys Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Femasys Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,023 shares of FEMY stock, worth $4,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,023

Previous 5,301 24.11%

Holding current value

$4,425

Previous $6,000 33.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.86 - $1.2 $1,099 - $1,533	-1,278 Reduced 24.11%	4,023 $4,000
Q2 2024 Aug 13, 2024	BUY	$0.96 - $1.81 $1,502 - $2,832	1,565 Added 41.89%	5,301 $6,000
Q1 2024 May 15, 2024	SELL	$0.75 - $2.22 $1,817 - $5,379	-2,423 Reduced 39.34%	3,736 $5,000
Q4 2023 Feb 13, 2024	SELL	$0.76 - $3.89 $2,764 - $14,147	-3,637 Reduced 37.13%	6,159 $6,000
Q3 2023 Nov 14, 2023	BUY	$0.31 - $2.98 $553 - $5,322	1,786 Added 22.3%	9,796 $29,000
Q2 2023 Aug 14, 2023	BUY	$0.51 - $1.26 $673 - $1,664	1,321 Added 19.75%	8,010 $4,000
Q1 2023 May 09, 2023	SELL	$0.85 - $1.29 $1,580 - $2,398	-1,859 Reduced 21.75%	6,689 $7,000
Q4 2022 Feb 10, 2023	BUY	$0.83 - $1.41 $147 - $250	178 Added 2.13%	8,548 $8,000
Q3 2022 Nov 10, 2022	SELL	$1.13 - $2.54 $1,909 - $4,292	-1,690 Reduced 16.8%	8,370 $9,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.76 $11,468 - $24,348	8,822 Added 712.6%	10,060 $24,000
Q1 2022 May 12, 2022	BUY	$1.76 - $3.99 $1,311 - $2,972	745 Added 151.12%	1,238 $3,000
Q4 2021 Feb 14, 2022	SELL	$3.49 - $8.02 $663 - $1,523	-190 Reduced 27.82%	493 $2,000
Q3 2021 Nov 15, 2021	BUY	$6.52 - $8.5 $4,453 - $5,805	683 New	683 $5,000

Others Institutions Holding FEMY

# of Institutions

Shares Held

1.63M

Call Options Held

Put Options Held

View Full List

About FEMASYS INC

Ticker FEMY
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 11,813,600
Market Cap $13M
Description
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...

More about FEMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Femasys Inc Transaction History